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Streptococcus pneumoniae contains a large number of sugar-transport systems
and the system responsible for rafﬁnose uptake has recently been identiﬁed. The
substrate-binding protein component of this system shares strong sequence
homology with the multiple sugar metabolism substrate-binding protein MsmE
from S. mutans and contains a lipoprotein-attachment site at cysteine residue 23.
A truncated form (residues 24–419) of RafE from S. pneumoniae was cloned and
overexpressed in Escherichiacoli. Native and selenomethionine-labelled protein
have been crystallized in the hexagonal space group P6122. Diffraction data
have been successfully phased to 2.90 A ˚ using Se SAD data and model building
is in progress.
1. Introduction
Streptococcus pneumoniae is a major human pathogen that mainly
affects the young, elderly and immunocompromized populations.
Pneumococcal infection is estimated to kill over one million children
under the age of ﬁve annually, with the majority of these deaths
occurring in developing countries (World Health Organization, 1999).
Genomic analysis of S. pnemoniae TIGR4 reveals a high level of
carbohydrate utilization in comparison to other species (Haemo-
philus inﬂuenzae and Neisseria meningitidis) that colonize the human
upper respiratory tract (Tettelin et al., 2001). Over 30% of the
transport systems found in the pneumococcus genome are predicted
to be sugar transporters, with a high proportion of these being ATP-
binding cassette (ABC) transporters. Bacterial ABC transporters
play an important role in organism virulence and also have
immunogenic potential (Garmory & Titball, 2004).
S. pneumoniae TIGR4 open reading frame SP1897 encodes a
protein, designated RafE, that is predicted to be the substrate-
binding component of an ATP-binding cassette (ABC) transport
system (Rosenow et al., 1999). It shares 60.3% sequence identity
(76.7% similarity) with MsmE from S. mutans, the substrate-binding
domain of an ABC transport system responsible for the uptake of
multiple sugars including rafﬁnose, melibiose and isomaltotriose
(Russell et al., 1992). In common with substrate-binding proteins
from other Gram-positive bacteria (Gilson et al., 1988), MsmE
contains a lipid-attachment site (conserved in RafE), which allows
anchoring of the protein to the cell membrane by cleavage upstream
of cysteine residue 23 and attachment of a fatty-acid lipid (Sutcliffe et
al., 1993). It appears that sequence differences between RafE and
MsmE result in different substrate speciﬁcities, with RafE only
capable of rafﬁnose transport (Rosenow et al., 1999). We present here
preliminary crystallization and X-ray diffraction studies of a trun-
cated form of RafE.
2. Materials and methods
2.1. Cloning
A polymerase chain reaction (PCR) product containing the coding
region for a truncated form of RafE (residues 24–419) was cloned
between the BamHI and HindIII sites of the pQE-10 vector (Qiagen)
with an in-frame N-terminal His6 tag and linker (MRGSHHH-
HHHTDP). Transformation was carried out into Escherichia coli
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All rights reservedstrain BL21 (DE3) and the cells were grown overnight on LB–agar
plates containing 50 mgm l
 1 ampicillin at 310 K. Single colonies were
used to inoculate overnight cultures.
2.2. Expression and purification
2.2.1. Native RafE. Cultures for induction (8   1 l) were each
inoculated with 1 ml of a 10 ml 310 Kovernight LB culture containing
50 mgm l
 1 ampicillin and grown at 310 K. Isopropyl thio- -d-
galactoside (IPTG) was added to a ﬁnal concentration of 1 mM at
A600 = 0.6. After 16 h growth at 310 K, the cells were harvested by
centrifugation at 3500g and 277 K for 15 min. Cells were resuspended
in lysis buffer [50 mM Tris–HCl pH 8.0, 500 mM NaCl, 1  EDTA-
free protease-inhibitor tablet (Roche) per 25 ml] and lysed by soni-
cation (Status US200 with TT13 tip, 10   30 s bursts at 100% power).
Cell debris was pelleted by centrifugation at 8000g and 277 K for
15 min and any residual cell debris was removed by a further
centrifugation of the supernatant at 40 000g and 277 K for 20 min.
Supernatant was loaded onto an Ni–NTA (Qiagen) column
previously equilibrated with 50 mM Tris–HCl pH 8.0, 300 mM NaCl
and washed with this buffer until A280 was constant. Protein was
eluted with a gradient to 50 mM Tris–HCl pH 8.0, 300 mM NaCl,
500 mM imidazole. Eluted fractions containing RafE were pooled
and concentrated at 2000g and 277 K to 60 mg ml
 1 (Amicon, 10 kDa
molecular-weight cutoff), calculated using a theoretical extinction
coefﬁcient of 80 790 M
 1 cm
 1 (Gasteiger et al., 2005). Gel ﬁltration
was performed using a 100 ml Superdex 75 (Amersham) column
equilibrated with 10 mM Tris–HCl pH 8.0, 50 mM NaCl and a load
volume of 1 ml. Retardation of the protein through the column was
observed, possibly owing to interaction with the cross-linked
agarose–dextran matrix, and this allowed selection of an active form
of the protein. Eluted protein was judged to be over 95% pure by
SDS–PAGE analysis. The protein was then concentrated to
20 mg ml
 1 by centrifugation at 2000g and 277 K (Amicon, 10 kDa
molecular-weight cutoff).
2.2.2. Selenomethionine-labelled RafE. Sequence analysis of RafE
showed 11 non-terminal methionine residues and a molecular weight
of 46.7 kDa, making it a good candidate for phasing by seleno-
methionine labelling. Selenomethionine-labelled protein was pre-
pared using methionine-biosynthesis inhibition (Van Duyne et al.,
1993). A 10 ml 310 K overnight LB culture containing 50 mgm l
 1
ampicillin and 25 mgm l
 1 kanamycin was prepared and gently
pelleted by centrifugation at 2000g and 300 K for 5 min. This pellet
was resuspended in 10 ml M9 minimal medium pre-warmed to 310 K
and used to inoculate selenomethionine growth media comprising M9
minimum medium plus sterile ﬁltered MgSO4 (1 mM), glucose
[0.4%(w/v)], thiamine [0.00005%(w/v)] and FeSO4 (15 mM). Cells
were grown at 310 K to an A600 of 0.3, at which point l-seleno-
methionine (Acros Organics; 50 mg l
 1), l-leucine (50 mg l
 1),
l-lysine (100 mg l
 1), l-isoleucine (50 mg l
 1), l-phenylalanine
(100 mg l
 1), l-threonine (100 mg l
 1) and l-valine (50 mg l
 1) were
added, followed 15 min later by 1 mM IPTG. Cells were grown to
A600 = 1.0 and then harvested by centrifugation at 3500g and 277 K
for 15 min. Puriﬁcation of selenomethionine-labelled RafE was
carried out as previously described, with the addition of reducing
agent at each stage. Lysis and Ni–NTA buffers were supplemented
with 10 mM  -mercaptoethanol. Following elution from the Ni–NTA
column, 10 mM DTT was added to the protein and used in all
subsequent buffers. The retardation on the Superdex-75 column
previously described was also observed for selenomethonine-labelled
RafE. Incorporation of selenomethionine was checked by MALDI–
TOF mass spectroscopy and found to be 100%.
2.3. Crystallization and data collection
2.3.1. Native RafE. Crystallization trials were performed using the
sitting-drop vapour-diffusion method at 295 K with a protein
concentration of 20 mg ml
 1 in 10 mM Tris–HCl pH 8.0, 50 mM
NaCl. Initial screening was conducted using Hampton Research
24-well Cryschem Plates, a drop volume of 1.5 ml protein and 1.5 ml
reservoir solution and a reservoir volume of 750 ml. Drops were
mixed by aspiration. Screening was conducted using Hampton
Research Crystal Screens 1 and 2 (Jancarik & Kim, 1991), Emerald
Biosystems Wizard 1 and 2 and Cryo 1 and 2, Molecular Dimensions
Structure Screen 1 and 2 and a wide range of in-house conditions.
Initial screening revealed single crystals in Crystal Screen 2
condition No. 14 and Structure Screen 2 condition No. 29. Both
conditions are comprised of 2.0 M ammonium sulfate, 0.2 M sodium/
potassium tartrate, 0.1 M sodium citrate pH 5.6. Crystals appeared
after 3 d and continued growing for several months, but showed
relatively poor diffraction, with a resolution limit of around 4.5 A ˚ .
Optimizations using Additive Screens 1, 2 and 3 (Hampton Research)
with the original condition yielded crystals in 43 of the 72 conditions.
These were all ﬂash-cooled in liquid nitrogen using dry parafﬁn oil as
a cryoprotectant (Riboldi-Tunnicliffe & Hilgenfeld, 1999). Owing to
the large number of crystals, they were screened at the SRS Dares-
bury, beamline 14.2, using the Actor robotic system (Rigaku MSC).
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Table 1
Data-collection statistics for native and selenomethionine-labelled RafE.
Values in parentheses are for the highest resolution shell.
Data set Native SeMet (peak)
X-ray source 14.2 SRS 14.2 SRS
Wavelength (A ˚ ) 0.9790 0.9792
Space group P6122 P6122
Unit-cell parameters (A ˚ ,  )
a = b 145.10 144.54
c 226.98 224.08
  =   90.0 90.0
  120.0 120.0
Resolution limits (A ˚ ) 48.34–3.65 (3.78–3.65) 29.51–2.90 (3.00–2.90)
No. of observations 337049 668591
No. of unique observations 16328 57961
Average redundancy 20.64 (21.12) 11.54 (11.56)
Completeness (%) 100.0 (100.0) 100.0 (100.0)
hI/ (I)i 13.1 (7.1) 15.2 (5.4)
Rmerge† 0.113 (0.413) 0.083 (0.417)
† Rmerge =
P
jIobs   Iavgj=
P
Iavg.
Figure 1
Crystals of selenomethionine-labelled RafE. The dimensions of the largest crystal
are approximately 400   400   250 mm.Divalent cations proved the best additives, in particular MgCl2
(10 mM), CaCl2 (10 mM), CoCl2 (10 mM), CuCl2 (10 mM) and CdCl2
(10 mM), with diffraction visible to 3.65 A ˚ . Data were collected from
a crystal grown in 2.0 M ammonium sulfate, 0.1 M Tris–HCl, 0.2 M
sodium/potassium tartrate and CdCl2 (10 mM) at the SRS Daresbury,
beamline 14.2, using a MAR CCD detector and a crystal oscillation of
1  per frame. A summary of the data-collection statistics is given in
Table 1. The data were processed and scaled using the d*TREK
package (Pﬂugrath, 1999) with systematic absences indicating a space
groupofeitherP6122orP6522,withunit-cellparametersa=b=145.10,
c = 226.98 A ˚ ,  =   = 90.0,   = 120.0 . The number of molecules in the
asymmetric unit was also ambiguous at this stage, with either two
(VM =3 . 7 6 A ˚ 3 Da
 1, 67.33% solvent content), three (VM =
2.51 A ˚ 3 Da
 1, 50.99% solvent content) or four (VM =1 . 8 8A ˚ 3 Da
 1,
34.66% solvent content) molecules per asymmetric unit.
2.3.2. Selenomethionine-labelled RafE. Optimization of the initial
crystallization condition discovered for the native protein yielded
crystals that appeared identical to those previously obtained.
Adjusting the conditions to 1.8 M ammonium sulfate, 0.1 M sodium
citrate pH 5.1 and 0.2 M MgCl2 yielded the best-looking crystals
(Fig. 1) and these were ﬂash-cooled as previously described. An
XAFS scan at the SRS Daresbury, beamline 14.2, showed a strong
signal at the selenium edge and following analysis with CHOOCH
(Evans & Pettifer, 2001; Fig. 2), diffraction data were collected at the
peak wavelength of 0.9792 A ˚ . Fig. 2 shows the importance of
collecting an accurate ﬂuorescence scan from a selenomethionine-
labelled protein crystal, as collection at the theoretical selenium
absorption edge of 0.9795 A ˚ (12657.9 eV) would have missed the
actual absorption edge of this crystal and resulted in very low
anomalous signal. Data-collection statistics are shown in Table 1.
These data were processed and scaled using d*TREK and 33
potential Se sites were found using SnB (Blessing & Smith, 1999;
Smith et al., 1998; Turner et al., 1998; Weeks & Miller, 1999) with a
clear bimodal distribution of correct and incorrect solutions. The top
14 of these sites with peak height greater than 6  were subjected to
maximum-likelihood heavy-atom parameter reﬁnement using
SHARP (Bricogne et al., 2003) and an additional two sites were
identiﬁed from subsequent residual map analysis. Solvent ﬂattening
was performed using SOLOMON (Abrahams & Leslie, 1996) and
indicated an optimal solvent content of 69.8%, suggesting the
presence of two molecules per asymmetric unit, and produced readily
interpretable maps (Fig. 3) that conﬁrm the space group as P6122.
Maps generated in P6522 were uninterpretable.
3. Concluding remarks
Both native and selenomethionine-labelled RafE from S. pneumo-
niae have been crystallized in space group P6122 with two molecules
in the asymmetric unit. Phasing using selenomethionine SAD data
has been successful and has produced good-quality electron-density
maps, although it is clear that in the asymmetric unit one molecule is
well ordered while the other shows signiﬁcant disorder in a number of
regions. Of the 16 selenium sites found, 11 are from the well ordered
molecule and show clear density. Model building is currently in
progress and it appears that RafE shares the same periplasmic
binding protein fold as seen in other ABC substrate-binding protein
structures (Murzin et al., 1995).
We would like to thank the beamline staff at station 14.2, SRS for
help and support during data collection. This work was made possible
by a studentship awarded to NGP by the Biotechnology and Bio-
logical Sciences Research Council (BBSRC).
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